134 related articles for article (PubMed ID: 28834055)
1. Cost-effectiveness of sacral neuromodulation for chronic refractory constipation in children and adolescents: a Markov model analysis.
van der Wilt AA; Groenewoud HHM; Benninga MA; Dirksen CD; Baeten CGMI; Bouvy ND; Melenhorst J; Breukink SO
Colorectal Dis; 2017 Nov; 19(11):1013-1023. PubMed ID: 28834055
[TBL] [Abstract][Full Text] [Related]
2. Sacral neuromodulation in children and adolescents with chronic constipation refractory to conservative treatment.
van der Wilt AA; van Wunnik BP; Sturkenboom R; Han-Geurts IJ; Melenhorst J; Benninga MA; Baeten CG; Breukink SO
Int J Colorectal Dis; 2016 Aug; 31(8):1459-66. PubMed ID: 27294660
[TBL] [Abstract][Full Text] [Related]
3. Sacral neuromodulation versus personalized conservative treatment in patients with idiopathic slow-transit constipation: study protocol of the No.2-trial, a multicenter open-label randomized controlled trial and cost-effectiveness analysis.
Heemskerk SCM; Rotteveel AH; Benninga MA; Baeten CIM; Masclee AAM; Melenhorst J; van Kuijk SMJ; Dirksen CD; Breukink SO
Int J Colorectal Dis; 2018 Apr; 33(4):493-501. PubMed ID: 29470731
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of intractable constipation treated by sacral neuromodulation: a comparison between children and adults.
Janssen PTJ; Meyer YM; Van Kuijk SMJ; Benninga MA; Stassen LPS; Bouvy ND; Melenhorst J; Breukink SO
Colorectal Dis; 2018 Feb; 20(2):134-143. PubMed ID: 28782277
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladder.
Arlandis S; Castro D; Errando C; Fernández E; Jiménez M; González P; Crespo C; Staeuble F; Rodríguez JM; Brosa M
Value Health; 2011; 14(2):219-28. PubMed ID: 21402292
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Sacral Neuromodulation in Children and Adolescents: A Case-Control Study of Patients With Chronic Refractory Constipation.
Diez S; Kirchgatter A; Adam D; Füldner A; Müller H; Matzel KE; Besendörfer M
Neuromodulation; 2023 Dec; 26(8):1858-1866. PubMed ID: 36207226
[TBL] [Abstract][Full Text] [Related]
7. Sacral Neuromodulation Versus Conservative Treatment for Refractory Idiopathic Slow-transit Constipation: The Randomized Clinical No.2-Trial.
Heemskerk SCM; Dirksen CD; van Kuijk SMJ; Benninga MA; Baeten CIM; Masclee AAM; Melenhorst J; Breukink SO
Ann Surg; 2024 May; 279(5):746-754. PubMed ID: 37991178
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness, safety and cost-effectiveness of sacral neuromodulation for idiopathic slow-transit constipation: a systematic review.
Heemskerk SCM; van der Wilt AA; Penninx BMF; Kleijnen J; Melenhorst J; Dirksen CD; Breukink SO
Colorectal Dis; 2024 Mar; 26(3):417-427. PubMed ID: 38247282
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder.
Leong RK; de Wachter SG; Joore MA; van Kerrebroeck PE
BJU Int; 2011 Aug; 108(4):558-64. PubMed ID: 21166750
[TBL] [Abstract][Full Text] [Related]
10. Sacral neuromodulation for constipation and fecal incontinence in children and adolescents - study protocol of a prospective, randomized trial on the application of invasive vs. non-invasive technique.
Besendörfer M; Kirchgatter A; Carbon R; Weiss C; Müller H; Matzel KE; Diez S
Trials; 2024 Mar; 25(1):210. PubMed ID: 38515199
[TBL] [Abstract][Full Text] [Related]
11. Sacral neuromodulation in children and adolescents with defecation disorders.
Besendörfer M; Knorr C; Kirchgatter A; Müller H; Reis Wolfertstetter P; Matzel KE; Diez S
Neurogastroenterol Motil; 2024 Jun; 36(6):e14808. PubMed ID: 38703048
[TBL] [Abstract][Full Text] [Related]
12. Sacral neuromodulation therapy: a promising treatment for adolescents with refractory functional constipation.
van Wunnik BP; Peeters B; Govaert B; Nieman FH; Benninga MA; Baeten CG
Dis Colon Rectum; 2012 Mar; 55(3):278-85. PubMed ID: 22469794
[TBL] [Abstract][Full Text] [Related]
13. Neuromodulation for constipation: sacral and transcutaneous stimulation.
van Wunnik BP; Baeten CG; Southwell BR
Best Pract Res Clin Gastroenterol; 2011 Feb; 25(1):181-91. PubMed ID: 21382589
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of sacral neuromodulation for chronic refractory constipation.
Maeda Y; Kamm MA; Vaizey CJ; Matzel KE; Johansson C; Rosen H; Baeten CG; Laurberg S
Tech Coloproctol; 2017 Apr; 21(4):277-286. PubMed ID: 28429130
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of sacral neuromodulation for faecal incontinence in The Netherlands.
van Wunnik BP; Visschers RG; van Asselt AD; Baeten CG
Colorectal Dis; 2012 Dec; 14(12):e807-14. PubMed ID: 22943485
[TBL] [Abstract][Full Text] [Related]
16. [Sacral neuromodulation in the treatment of intractable constipation].
Zheng J; Li S; Nie Y; Sun H; Wang M; Dai Y; Zhao H; Pang G; Wu G; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Dec; 17(12):1175-8. PubMed ID: 25529946
[TBL] [Abstract][Full Text] [Related]
17. Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation.
Martinson M; MacDiarmid S; Black E
J Urol; 2013 Jan; 189(1):210-6. PubMed ID: 23174264
[TBL] [Abstract][Full Text] [Related]
18. [Research progress of sacral neuromodulation procedure in the treatment of chronic constipation and fecal incontinence].
He C; Liu S; Li S; Zhang B; Zheng J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Apirl 25; 21(4):476-480. PubMed ID: 29682720
[TBL] [Abstract][Full Text] [Related]
19. A novel three-dimensional printed guiding device for electrode implantation of sacral neuromodulation.
Cui Z; Wang Z; Ye G; Zhang C; Wu G; Lv J
Colorectal Dis; 2018 Jan; 20(1):O26-O29. PubMed ID: 29110390
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain.
Brosa M; Muñoz-Duyos A; Navarro-Luna A; Rodriguez JM; Serrano D; Gisbert R; Dziekan K; Segú JL
Curr Med Res Opin; 2008 Mar; 24(3):907-18. PubMed ID: 18279582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
